Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.44 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.42 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.42 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9927903 | 1.00 | HRH3 (0.48) | HRH3SIGMAR1CARM1PRMT6PRMT8 | |
| SCHEMBL24891389 | 1.00 | HRH3 (0.48) | HRH3SIGMAR1CARM1PRMT6PRMT8 | |
| SCHEMBL24891390 | 1.00 | HRH3 (0.48) | HRH3SIGMAR1CARM1PRMT6PRMT8 | |
| SCHEMBL24891404 | 1.00 | HRH3 (0.48) | HRH3SIGMAR1CARM1PRMT6PRMT8 | |
| SCHEMBL3671614 | 0.97 | SIGMAR1 (0.46) | HRH3SIGMAR1CARM1PRMT6PRMT8 | |
| SCHEMBL9927905 | 0.92 | — | — | |
| SCHEMBL2231151 | 0.86 | PIM1 (0.42) | SIGMAR1 | |
| SCHEMBL1186740 | 0.86 | — | — | |
| SCHEMBL7649376 | 0.85 | HRH3 (0.56) | HRH3SIGMAR1SLC6A4 | |
| SCHEMBL791946 | 0.84 | SIGMAR1 (0.58) | SIGMAR1SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 819 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753408-B2 | Compounds and method for blocking transmission of malarial parasite | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | claimed |
| US-9279054-B2 | Sound-absorbent foam system | PREFORM GMBH (DE) | 2016-03-08 | — | — | US | claimed |
| US-20140171431-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) | 2014-06-19 | — | — | US | claimed |
| EP-2725024-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2014-04-30 | — | — | EP | claimed |
| US-20110057144-A1 | SOUND-ABSORBENT FOAM SYSTEM | PREFORM GMBH (DE) | 2011-03-10 | — | — | US | claimed |
| EP-2090621-B1 | Sound absorbing foam system | PREFORM GMBH (DE) | 2009-12-23 | — | — | EP | claimed |
| WO-2009103420-A1 | SOUND-ABSORBENT FOAM SYSTEM | PREFORM GMBH (DE) | 2009-08-27 | — | — | WO | claimed |
| EP-2090621-A1 | Sound absorbing foam system | Preform GmbH (DE) | 2009-08-19 | — | — | EP | claimed |
| EP-0604363-B1 | Stable solutions of accelerators for epoxy resins | VANTICO AG (CH) | 2003-02-12 | — | — | EP | claimed |
| US-6479672-B1 | Diastereoselective preparation of Michael adducts | MERCK & CO., INC. | 2002-11-12 | — | — | US | claimed |
| US-5470896-A | Storage-stable solutions of accelerator systems | CIBA-GEIGY CORPORATION (US) | 1995-11-28 | — | — | US | claimed |
| EP-0604363-A2 | Stable solutions of accelerators for epoxy resins | CIBA-GEIGY AG (CH) | 1994-06-29 | — | — | EP | claimed |
| US-12612485-B2 | Continuous production of polyurethane prepolymers | BASF SE (DE) | 2026-04-28 | — | — | US | disclosed |
| EP-4720146-A1 | RIGID POLYISOCYANURATE FOAMS OBTAINABLE USING POLYETHYLENE TEREPHTHALATE-BASED ESTERS | BASF SE (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | disclosed |
| EP-4601880-B1 | RETORTABLE SOLVENT FREE LAMINATION ADHESIVES | SUN CHEMICAL BV (NL) | 2026-02-18 | — | — | EP | disclosed |
| EP-0433889-A2 | Process for the preparation of polyurethane soft foams with low compression hardness and mixtures of polyoxypropylene-polyoxyethylene block polyols suitable therefor | BASF Aktiengesellschaft (DE) | 1991-06-26 | — | — | EP | disclosed |
| EP-0433878-A2 | Process for the preparation of flexible polyurethane foams with viscoelastic, body-sound damping properties and the polyalkoxide-polyol blends for this process | BASF Aktiengesellschaft (DE) | 1991-06-26 | — | — | EP | disclosed |
| EP-0377891-A2 | Process for the preparation of fire-retardant elastic flexible polyurethane foams, and low viscosity melamine polyether dispersions therefor | BASF Aktiengesellschaft (DE) | 1990-07-18 | — | — | EP | disclosed |
| EP-0219706-A1 | N,N-dialkylaminoalkyl-hexahydro-5-oxo-1H-pyrrolizine-3-carboxamides | WARNER-LAMBERT COMPANY (US) | 1987-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | URB2, UQCRB, UQCRC2 | HRH3 93/4885SIGMAR1 400/4885CARM1 779/4885 |
| US-12612485-B2 | Continuous production of polyurethane prepolymers | UROD, HPD, PGD | HRH3 2479/4885SIGMAR1 2486/4885CARM1 3314/4885 |
| US-20140171431-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | PLA2G5, LTA4H, PLA2G4A | HRH3 559/4885SIGMAR1 4568/4885CARM1 3258/4885 |
| US-11753408-B2 | Compounds and method for blocking transmission of malarial parasite | PLK1, HSP90B1, CEP170 | HRH3 2849/4885SIGMAR1 1506/4885CARM1 3076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.